Breaking News

Patient with transplanted pig kidney had a ‘tense’ rejection episode before leaving the hospital

April 8, 2024
Xenotransplant recipient Richard Slayman, holding hands with his partner Faren, poses with Leonardo Riella (left), medical director of kidney transplantation at Massachusetts General Hospital, and other members of his medical team before going home.
Michelle Rose/Massachusetts General Hospital

Patient with transplanted pig kidney had a 'tense' rejection episode before leaving the hospital

Transplant patient Richard Slayman has shown no further signs of organ distress since going home last week, a Mass General physician said.

By Megan Molteni


STAT+ | New liquid biopsy screening test for pancreatic cancer shows promise in early data

The key to saving more pancreatic cancer patients is not just improving treatment but finding a better way to discover the cancer early.

By Angus Chen


STAT+ | Device made by company J&J is buying for $13 billion clears hurdle in independent study

A device from Shockwave Medical, which is being bought by J&J, might work in reducing chest pain, according to independent study.

By Lizzy Lawrence and Matthew Herper



Christine Kao/STAT

STAT+ | HCA reports almost $1 billion more in charity care to Medicare than to its shareholders, drawing more taxpayer money

The way HCA Healthcare does its reporting appears to be allowed under CMS' rules, but some argue it's not true charity care.

By Tara Bannow


STAT+ | FDA agrees to review a rare disease drug that its developer was about to give up on

The move comes after Stealth BioTherapeutics spent a decade navigating FDA bureaucracy and burning through $75 million.

By Ed Silverman


HCA's charity care filings are on hyperdrive

The country's biggest hospital chain told the government it doled out almost $1 billion more in charity care in 2022 than it reported to shareholders.

By Bob Herman


Adobe

Opinion: The time has come for over-the-counter antidepressants

SSRI antidepressants meet the FDA's requirements for over-the-counter medicines. It's time to give them that status.

By Roy Perlis


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments